Recent Patents on Anti-Cancer Drug Discovery 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Natural STAT3 inhibitors for cancer treatment: A Comprehensive Literature Review
Recent Pat Anticancer Drug Discov. 2023 Aug 3. doi: 10.2174/1574892818666230803100554. Online ahead of print.ABSTRACTCancer is one of the leading causes of mortality and morbidity worldwide, affecting millions of people physically and financially every year. Over time, many anticancer treatments have been proposed and studied, including synthetic compound consumption, surgical procedures, or grueling chemotherapy. Although these treatments have improved the daily life quality of patients and increased their survival rate and life expectancy, they have also shown significant drawbacks, including staggering costs, multiple s...
Source: Recent Patents on Anti-Cancer Drug Discovery - August 3, 2023 Category: Cancer & Oncology Authors: Seyed Mahdi Zarezadeh Amir Mohammad Sharafi Gisou Erabi Arefeh Tabashiri Navid Teymouri Hoda Mehrabi S Amirhossein Golzan Arezoo Faridzadeh Zahra Abdollahifar Nafiseh Sami Javad Arabpour Zahra Rahimi Arina Ansari Mohammadreza Abbasi Nima Azizi Amirhossein Source Type: research
1,3,4-Oxadiazoles as Anticancer Agents: A Review
Recent Pat Anticancer Drug Discov. 2023 Jul 27. doi: 10.2174/1574892818666230727102928. Online ahead of print.ABSTRACTAmong the deadliest diseases, cancer is characterized by tumors or an increased number of a specific type of cell because of uncontrolled divisions during mitosis. Researchers in the current era are concentrated on the development of highly selective anticancer medications due to the substantial toxicities of conventional cytotoxic drugs. Several marketed drug molecules have provided resistance against cancer through interaction with certain targets/growth factors/enzymes, such as Telomerase, Histone deacet...
Source: Recent Patents on Anti-Cancer Drug Discovery - July 27, 2023 Category: Cancer & Oncology Authors: Greesh Kumar Rajnish Kumar Avijit Mazumder None Salahuddin Upendra Kumar Source Type: research
Predictive modelling of overall survival in adult patients with primary diffuse large B-cell lymphoma of the breast using the Surveillance, Epidemiology, and End Results (SEER) database
CONCLUSION: For patients with PB-DLBCL, a more convenient and accurate web-based prediction model was developed and validated, which showed relatively good performances in both discrimination and calibration during model development and validation. External evaluation and validation are warranted by further independent studies.PMID:37464821 | DOI:10.2174/1574892818666230718153721 (Source: Recent Patents on Anti-Cancer Drug Discovery)
Source: Recent Patents on Anti-Cancer Drug Discovery - July 19, 2023 Category: Cancer & Oncology Authors: Yishuai Liu Haifeng Han Hong Wei Xinlong Wang Zhaotang Luan Kun Jiang Source Type: research
